Related Experiment Video
Updated: Aug 11, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
DNA hypermethylation of TIMP3 gene in invasive breast ductal carcinoma
1Department of Surgery, University of Hong Kong Medical Center, Queen Mary Hospital, Pokfulam.
Background:
Neoplastic cells often display aberrant methylation and silencing of multiple genes, including tumor suppressor genes (TSGs) that regulate critical processes such as cell cycle control, DNA repair and angiogenesis. Tissue inhibitor of metalloproteinase-3 (TIMP3) is an extracellular matrix-bound protein which regulates matrix composition and affects tumor growth, invasion and angiogenesis. It mediates vascular endothelial growth factor (VEGF) by blocking the binding of VEGF to VEGF receptor-2 and inhibits downstream signaling. This study focused on the hypermethylation status of the TIMP3 gene with clinical parameters in invasive breast ductal carcinoma (IDC) samples.
Materials And Methods:
DNA extraction and methylation specific PCR (MSP) was performed on 173 patients with invasive breast carcinoma. Both specific methylated and unmethylated primers for each gene were used for PCR and the products were visualized on agarose gel. The methylation status of TIMP3 was then compared with corresponding patients' clinicopathologic characteristics.
Results:
Methylation frequencies of TIMP3 in the breast cancer samples were 20.81 %. Among the hypermethylated cancers, 50% were tumor grade II-III, 44.44% were positive in lymph node involvement (LN), 36.11% were positive in lymphovascular permeation (LVP); 44.44%, 22.22% and 47.22% for the overexpressions in estrogen receptor (ER), progesterone receptor(PR) and c-erbB2, respectively.
Conclusion:
The result demonstrated that hypermethylation of TIMP3 in IDC might be associated with high tumor grading and lymph nodes metastasis, and overexpression of ER, PR and c-erbB2, respectively.
Insights
Hypermethylation of the TIMP3 gene was observed in 20.81% of invasive breast cancers. This gene silencing may correlate with aggressive tumor features like high grade, lymph node metastasis, and specific receptor overexpressions.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Neoplastic cells exhibit aberrant methylation, silencing tumor suppressor genes (TSGs) crucial for cell cycle control, DNA repair, and angiogenesis.
- Tissue inhibitor of metalloproteinase-3 (TIMP3) is an extracellular matrix protein influencing tumor growth, invasion, and angiogenesis by mediating vascular endothelial growth factor (VEGF) signaling.
- Aberrant methylation of TIMP3 can disrupt its regulatory functions in cancer development.
Purpose of the Study:
- To investigate the hypermethylation status of the TIMP3 gene in invasive breast ductal carcinoma (IDC).
- To correlate TIMP3 gene hypermethylation with key clinical and pathological parameters in breast cancer patients.
Main Methods:
- DNA extraction and methylation-specific PCR (MSP) were performed on 173 invasive breast carcinoma samples.
- Methylated and unmethylated primers were used to assess TIMP3 gene methylation.
- Clinicopathological characteristics were compared with the methylation status of TIMP3.
Main Results:
- TIMP3 gene hypermethylation was detected in 20.81% of breast cancer samples.
- Hypermethylated tumors showed associations with higher tumor grade (II-III), lymph node involvement (44.44%), and lymphovascular permeation (36.11%).
- TIMP3 hypermethylation correlated with overexpression of estrogen receptor (ER) (44.44%), progesterone receptor (PR) (22.22%), and c-erbB2 (47.22%).
Conclusions:
- Hypermethylation of the TIMP3 gene in IDC is potentially linked to advanced tumor grading and lymph node metastasis.
- TIMP3 gene hypermethylation may also be associated with the overexpression of ER, PR, and c-erbB2 in breast cancer.
- These findings suggest TIMP3 methylation as a potential biomarker in breast cancer progression.
Related Concept Videos
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
